ure that resembles human sepsis. Because of the central role of the liver in sepsis, we performed DIGE on this tissue with the objective of discovering new drug targets. A similar gel-based proteomic approach has been successful in the investigation of liver fibrosis and drug toxicity (7, 8) . In our sepsis model, it is the development of acute renal failure that predicts mortality. We demonstrated this using a novel magnetic resonance imaging technique, and it is consistent with human studies that demonstrate acute renal failure in a septic patient increases mortality (9, 10) . Therefore, we used renal function as the end point to evaluate the efficacy of drug intervention.
METHODS
Animals. Animal care followed National Institutes of Health criteria for the care and use of laboratory animals. Three-month-old C57BL/6 mice were obtained from Jackson Laboratory (Bar Harbor, ME). The mice had free access to water and food (NIH-07 Rodent Chow, Zeigler Bros., Gardners, PA) before and after surgery.
Cecal Ligation and Puncture. The mice were anesthetized and polymicrobial sepsis was induced by performing CLP as previously described (5) . All animals received a broadspectrum antibiotic (imipenem/cilastatin, 14 mg/kg subcutaneously) in 1.5 mL of three quarters normal saline at 6 hrs after surgery and then every 12 hrs. At the time of kill, blood was collected by cardiac puncture. The liver was then harvested for histologic evaluation, proteomic investigation, and immunoblotting. The 10% formalin-fixed liver sections were stained with periodic acid-Schiff reagent. For proteomic investigation, the liver tissue was homogenized in lysis buffer (see below). For immunoblotting, the liver tissue was homogenized on ice in T-PER (Pierce, Rockford, IL) with complete miniprotease inhibitors (Roche, Indianapolis, IN). Samples were aliquoted and stored at Ϫ80°C before use.
In a subsequent target validation study, CLP was performed as above, but either anti-CD147 antibody (25 g) or isotype control antibody was administered intraperitoneally at the time of surgery, 6 hrs afterward, and 18 hrs afterward. Blood was obtained and organs harvested 24 hrs after CLP surgery.
Two-Dimensional Difference in Gel Electrophoresis. We investigated sepsis-induced changes in the liver proteome by DIGE. Liver was homogenized in 7 mol/L urea, 2 mol/L thiourea, 4% 3-[(3-cholamidopropyl)dimethylammonio]-1-propane sulphonate, and 30 mmol/L Tris·HCl (pH 8.8) (BioVision, Mountain View, CA), and the protein concentration of the samples was determined using the 2-D Quant kit (Amersham, Bucks, UK). Liver pro-tein (50 g) was then minimally labeled with Cye dyes as per manufacturer's instructions (200 pmol per sample).
Two discovery experiments were performed to determine early (6 hrs post-CLP vs. 6 hrs after sham surgery) and late (24 hrs post-CLP vs. 6 hrs post-CLP) changes in hepatic protein abundance. We used a dye-swap replication protocol for the discovery phase, and a parallel cutting gel for the identification phase ( Table 1 ). The first three gels use biological replication to increase statistical power, and the dye swap reduces labeling artifacts. The cutting gel contains a larger quantity of unlabeled protein to enhance the proteomic identification by matrix assisted laser desorption/ionization mass spectrometry and tandem mass spectrometry.
Each discovery experiment used six mice, three per treatment group. The Cy2-labeled internal standard on each gel was created by pooling 8.3 g of liver protein from each of the six mice in an experiment (i.e., 50 g total). The cutting gel (gel 4) was created by pooling 100 g of liver protein from each mouse.
Cy2-, Cy3-, and Cy5-labeled samples were mixed together and rehydration buffer was added (7 mol/L urea, 2 mol/L thiourea, 4% 3-[(3-cholamidopropyl)dimethylammonio]-1propane sulphonate, 0.5% pharmalytes (Amersham), 40 mmol/L dithiothreitol, and 0.002% bromophenol blue) to a final volume of 450 L. The samples were then loaded on an immobilized pH gradient strip (24 cm, pH 3-10) for isoelectric focusing according to the following protocol: 30 V for 14 hrs (active rehydration), 500 V for 1 hr, 1,000 V for 1 hr, and 8,000 V for 8.33 hrs. Strips were equilibrated for 15 mins in a solution containing 50 mmol/L Tris·HCl (pH 8.8), 6 mol/L urea, 30% glycerol, 2% sodium dodecyl sulfate, 0.002% bromophenol blue, and 65 mmol/L dithiothreitol, followed by a second 15-min equilibration with iodoacetamide (25 mg/mL) instead of dithiothreitol. Strips were briefly rinsed in 1ϫ sodium dodecyl sulfate polyacrylamide gel electrophoresis buffer and applied to a 12.5% polyacrylamide gel for electrophoresis at 5W/ gel for 30 mins followed by 17W/gel for 4 hrs. Image Acquisition and Analysis. Images were scanned on a Typhoon 9400 variable mode imager (Amersham Biosciences, Piscataway, NJ) at an excitation wavelength of 520/40 (488-nm, blue 2 laser) for Cy2-, 580/30 (532-nm, green laser) for Cy3-, and 670/30 (633-nm, red laser) for Cy5-labeled samples. The laser power was chosen so that no saturated signal was obtained from any protein spot. The resolution was 100 m. Images were then processed with Progenesis Discovery software (Nonlinear Dynamics, Newcastle, UK). The software subtracts the background signal using a subtraction algorithm and quantifies spot intensity based on normalized spot volume. The normalization is ratiometric with Cy3 and Cy5 images being expressed as a ratio of the corresponding Cy2 internal standard protein spot. Statistical significance was determined by a two-sided Student's t-test. Spot fluorescence intensities that were significantly increased or decreased with treatment were selected for identification. Selection was based on the change in intensity being statistically significant. No cutoff value for fold change was applied in order to maximize the yield of spots of interest.
After protein spots were designated to be picked, the gel with 600 g of protein was fixed overnight in 30% ethanol and 3% phosphoric acid, then stained in Coomassie blue stain for 2 days. Then the gel was washed with water for 24 hrs. Next, the gel was scanned at an excitation wavelength of 610/30 (532-nm laser) to visualize proteins present in the gel. Images derived from Cye dye and Coomassie blue were matched using Progenesis software, from which a pick list was generated.
Spot Picking and Protein Processing. The Ettan Spot Handling Workstation (GE Healthcare, Waukesha, WI) was used to subsequently cut out the selected protein spots from the 600-g protein gel, perform an in-gel tryptic digestion, extract the peptides from the gel, and transfer the digested proteins on a MALDI-TOF/Pro (Amersham Biosciences) sample slide. Peptides were analyzed using a 4700 Proteomics Analyzer (Applied Biosystems, Foster City, CA) tandem mass spectrometer.
Western Blotting. Changes in protein abundance identified by DIGE were confirmed by Western blot. The following antibodies were used: cyclophilin (USBiological, Swampscott, MA), regucalcin (Cell Sciences, Canton, MA), superoxide dismutase (USBiological), and catalase (Rockland, Gilbertsville, PA). Western blot was performed as previously described (11) . Equal protein loading for each lane was confirmed by immunoblotting for ␤-tubulin.
Statistical Analysis. All data are expressed as mean Ϯ SE. Differences between groups were analyzed for statistical significance by two-sided Student's t-test. When the statistical significance of a change in protein abundance (from DIGE experiments) was determined by t-test, the log ratios of the protein fold change were analyzed. p Ͻ .05 was accepted as statistically significant.
RESULTS
Liver injury occurred after CLP ( Figs. 1 and 2) . At both 6 hrs and 24 hrs after CLP, there was an elevation in both serum aspartate transaminase and alanine transaminase ( Fig. 1 ). At 6 hrs and 24 hrs after CLP, there also was injury on histologic examination of the tissue (Fig.  2) . The sham-treated mouse liver was normal, with even distribution of glyco-gen in hepatocytes and no evidence of lymphocyte infiltrate or Kupffer cell reactivity. At 6 hrs post-CLP, the liver showed loss of hepatocyte glycogen in watershed zones distant to vessels. Kupffer cells showed nuclear enlargement, and were prominent with mild dilation of sinuses. After 24 hrs, the liver was pale with loss of glycogen stores in all hepatocytes. Nuclei show altered chromatin rimming the nucleus. Kupffer cells were prominent, and rare scattered neutrophils were present in the background.
We used DIGE to compare the liver proteome 6 hrs after CLP surgery with 6 hrs after sham surgery (experiment 1, early protein changes). In a second experiment, the liver proteome 6 hrs after CLP surgery was compared with the liver proteome 24 hrs after CLP surgery (experi- Proteins were identified by MALDI-TOF-TOF. The change is expressed as fold increase or decrease of protein abundance at 6 hrs post-CLP vs. sham surgery (SE of the mean fold change). A positive percentage indicates an increase at 6 hrs of sepsis; a negative percentage indicates a decrease at 6 hrs of sepsis. The measured molecular weight (MW) and measured isoelectric point (PI) were determined from the 2-dimensional gel. Also shown are the predicted MW and PI. The identifications were made by peptide mass fingerprinting and tandem mass spectrometry for most proteins, and the scores are shown as a percentage. The change is expressed as fold increase or decrease protein abundance of 24 hrs vs. 6 hrs post-CLP (SE of the mean fold change. A positive percentage indicates that protein abundance is increasing; a negative percentage indicates that protein abundance is decreasing. Data are displayed as in Table 2. ment 2, late protein changes). Figure 3 shows a typical 2D gel with examples of two proteins that changed in abundance. For experiment 1, 72 spots were selected, of which 44 were correctly identified. For experiment 2, 62 spots were selected, of which 52 were correctly identified. Identification was considered correct if the peptide mass fingerprinting score was above 90% and the measured molecular weights and isoelectric points matched the expected values (Tables 2 and 3) . The majority of the proteins identified had additional validation by amino acid sequencing with tandem mass spectrometry (Tables 2 and 3 ). The proteins that changed in abundance are shown graphically in Figure 4 and Figure 5 . Figure 6 compares changes in protein abundance as measured by DIGE and Western blot. The changes detected by DIGE and by Western blotting were always in the same direction and of comparable magnitude.
Cyclophilin was one liver protein that changed in abundance following CLP, both by DIGE and Western blot (Fig. 7) . CD147 is a signaling receptor for extracellular cyclophilin, and an antibody to this receptor was found to be antiinflammatory in a mouse model of asthma (12) . When we inhibited this receptor with a specific blocking antibody, there was a significant reduction in CLPinduced renal injury measured by both blood urea nitrogen and serum creatinine (Fig. 8 ). There was also a significant reduction in serum tumor necrosis factor-␣, interleukin (IL)-6, and IL-10 concentrations 24 hrs post-CLP when anti-CD147 antibody was compared with the sham-treated tissue ( Fig. 9 ) (serum tumor necrosis factor-␣ 24 hrs post-CLP: sham antibody 225 Ϯ 40 pg/mL, anti-CD147 antibody 105 Ϯ 25 pg/mL, n ϭ 8; p ϭ .03) (serum IL-6 24 hrs post-CLP: sham antibody 82 Ϯ 14 ng/mL, anti-CD147 antibody 16 Ϯ 7 ng/mL, n ϭ 8; p ϭ .01) (serum IL-10 24 hrs post-CLP: sham antibody 1370 Ϯ 146 pg/mL, anti-CD147 antibody 667 Ϯ 265 pg/mL, n ϭ 8; p ϭ .03). Serum amylase concentration also was reduced by the antibody, but there was no significant difference in serum transaminase concentration (Fig. 10 ).
DISCUSSION
In this study, we used the CLP model of polymicrobial sepsis to induce liver injury and used DIGE to explore changes in the liver proteome. These tissue changes were validated by Western blot. Recent studies have demonstrated that extracellular cyclophilin is proinflammatory via the CD147 receptor and that anti-CD147 antibodies are anti-inflammatory (12) (13) (14) (15) (16) . Administration of anti-CD147 antibodies significantly reduced sepsisinduced acute renal failure and reduced both pro-and anti-inflammatory cytokine production.
The liver proteins that changed in abundance with sepsis had a range of functions such as acute phase response, coagulation, ER stress, oxidative stress, apoptosis, mitochondrial electron transfer proteins, and nitric oxide metabolism. Six hrs after CLP, the protein with the largest increase in abundance was calgranulin B. This protein is a marker of neutrophils and has been demonstrated to be elevated in liver after administration of endotoxin (17) . Fibrinogen ␤-precursor had the largest decrease 6 hrs post-CLP. Changes in coagulation are well-described in sepsis (18) . After 24 hrs, the proteins with the largest increase relate to amyloid formation. Among the proteins with the largest decrease 24 hrs after CLP is carbamoyl phosphate synthetase. Fragmentation of this protein occurs in the liver after LPS administration and fragments can be detected in the serum (19) . We will discuss the possible significance of a few of the results, then focus on cyclophilin in the pathophysiology of sepsis.
Catalase protein levels changed in abundance consistent with the presence of oxidative stress in the liver after CLP (as described previously [20] ). The in-crease in the enzyme cysteine sulfinate decarboxylase also may reflect oxidative stress. This enzyme is important in taurine synthesis, and taurine plays an important role in the antioxidant response to inflammation (21) . For example, after bacterial injection into rats, taurine synthesis increases in the liver as an antioxidant mechanism (22) . Glutathione is another important antioxidant, and glutathione-s-transferase was increased in the liver after CLP consistent with previous reports (23, 24) .
The decrease in AdoMet synthetase after CLP is a novel finding, which is interesting because the product of this enzyme, S-adenosylmethionine, has antiinflammatory properties such as inhibition of cytokine production by Kupffer cells after LPS exposure in vitro and reduction of mortality after LPS injection in vivo (25) (26) (27) .
Regucalcin (senescence marker protein-30) is a calcium-regulated aging marker for which gene transcription is regulated by LPS (28) . It has been found to be a biomarker of carbon tetrachloride-induced liver injury (29) . By DIGE and Western blot, we found the liver abundance was increased early after CLP, which is interesting because senescence marker protein-30 has been demonstrated to protect hepatocytes from tumor necrosis factor-␣ and Fas-induced hepatocyte apoptosis in vivo (30) .
NG,NG-dimethylarginine dimethylaminohydrolase 1 hydrolyzes asymmetric dimethylarginine, which acts as an inhibitor of nitric oxide synthesis; therefore, this enzyme has a regulatory role in nitric oxide generation (31, 32) . Nitric oxide may be toxic or protective in the liver in sepsis (33) . Changes in levels of NG,NG-dimethylarginine dimethylaminohydrolase 1 in sepsis may reflect low liver blood flow, as has been demonstrated in the dog heart by two-dimensional electrophoresis (34) . Cyclophilin A is an abundant intracellular protein and is the target for the immunosuppressive drug cyclosporine (reviewed by Dr. Yurchenko and col-leagues (16)). Cyclophilin is released by cells in response to inflammation, and elevated serum levels have been demonstrated in humans with severe sepsis (35) .
Cyclophilin has pro-inflammatory actions, for example as a chemotactic agent for inflammatory cells (13) and an activator of endothelial cells (14, 15) . Therefore, we chose this protein as a potential therapeutic target. Yeast two-hybrid studies identified CD147 as an extracellular receptor for cyclophilin, and further studies demonstrated that this receptor mediates the pro-inflammatory actions of cyclophilin (16) . In our study, when we inhibited CD147 we significantly reduced sepsis-induced renal injury. Our previous studies have demonstrated that renal dysfunction predicts mortality following CLP (10) , which is consistent with human studies that demonstrate acute renal failure in a septic patient increases mortality (9) . Thus far, in humans, few therapeutic interventions have successfully reduced the incidence of sepsis-induced acute renal failure. Therefore, drugs targeting inhibition of cyclophilin offer a potential much-needed novel therapy. We also found reduced serum levels of tumor necrosis factor-␣, IL-6, and IL-10 cytokines after anti-CD147 antibody administration. This is consistent with the proinflammatory action of cyclophilin in other models (12) . Serum amylase concentration is significantly elevated after CLP, and this elevation was significantly reduced by administration of anti-CD147 antibody. This may reflect a reduction in pancreatic injury or be a result of the reduction in renal injury due to amylase being excreted via the kidneys (36) .
There are still significant questions regarding the role of cyclophilin in sepsis. The critical site of cyclophilin release is unknown. We demonstrated an increase in the liver, a central organ in sepsis pathophysiology, but whether other organs play a more or less significant role is unknown. It is interesting that administration of anti-CD147 antibody did not significantly reduce sepsis-induced liver injury as measured by serum aspartate transaminase and alanine transaminase levels. This may be another indication that different pathways mediate injury in the liver as compared with the kidney (6), or may represent a type 2 statistical error secondary to the insensitivity of transaminase enzymes at detecting liver dysfunction. However, using mice lacking the protein MyD88, we previously demonstrated that the degree of liver injury (as measured by serum aspartate transaminase and alanine transaminase) does not correspond with sepsis mortality, but renal injury closely predicted survival (6, 10) . Therefore, we believe it is an important finding that anti-CD147 prevented acute renal failure even in the absence of a significant effect on liver injury.
As a proteomic discovery technique, DIGE has limitations. A number of proteins that changed levels following sepsis will not have been identified. Such false negatives will occur with gel-based proteomics because of multiple reasons, such as difficulty in detecting lowabundance proteins or the inability to solubilize membrane proteins. Given that we used correct isoelectric point and molecular weight as criteria for protein identification, we will have missed a number of post-translational modifications. Even high-abundance, soluble proteins may not be amenable to identification by mass spectrometry because of technical limitations. Approaches that are more likely to complement DIGE and result in greater coverage of the proteome, such as separation by liquid chromatography before identification by mass spectrometry or protein antibody arrays, will further increase our understanding of sepsis (3). Also, advances in mass spectrometry will increase the identification rate of interesting proteins. 
